AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 11932266
Drug: Dihydrotestosterone (DHT)
RxNorm normalized name: 2α-Methyl-4,5-dihydrotestosterone propionate
DrugBank: Stanolone acetate (DB13951)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dihydrotestosterone (DHT) gel, administered transdermally for 6 months, dosage varied from 125-250 mg/d
Trial: 28317660
Drug: Intradermal with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intradermal with DebioJect™ (IDJ)
Trial: 16478005
Drug: amoxicillin capsule
RxNorm normalized name: Amoxicillin Capsules
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: amoxicillin capsule (reference)
Trial: 11136838
Drug: ABMT arm
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ABMT arm (high-dose chemotherapy plus autologous bone marrow transplantation)
Trial: 24659740
Drug: Control arm
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control arm (standard chemotherapy)
Trial: 30903410
Drug: Bone allograft
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bone allograft with gentamicin (8 mg gentamicin/gram bone solution for 1 hour)
Trial: 10432132
Drug: Transdermal progesterone
RxNorm normalized name: Progesterone
DrugBank: Progesterone (DB00396)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Transdermal progesterone cream
Trial: 19294776
Drug: Pharmaceutical-grade heroin
RxNorm normalized name: heroin
DrugBank: Diamorphine (DB01452)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmaceutical-grade heroin under medical supervision
Trial: 11783226
Drug: Composite Xiansu
RxNorm normalized name: methyl salicylate
DrugBank: Methyl salicylate (DB09543)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Composite Xiansu Capsule (CXSC) combined with chemotherapy
Trial: 7974373
Drug: CRVO patients
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CRVO patients with Lp(a) > 300 mg/l
Trial: 1157027
Drug: Postoperative irradiation
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Postoperative irradiation therapy
Trial: 17694218
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg of 1% ropivacaine gel (ropivacaine‐60)
Trial: 17694218
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg of benzocaine gel (benzocaine‐20)
Trial: 15990633
Drug: Enteral glutamine
RxNorm normalized name: Glutamine
DrugBank: L-Glutamine (DB00130)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Enteral glutamine supplementation (0.3 g/kg per day)
Trial: 1394916
Drug: mebendazole composite
RxNorm normalized name: Mebendazole
DrugBank: Mebendazole (DB00643)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: mebendazole composite (mebendazole 100 mg and levamisole 25mg bid x 3d)
Trial: 8477961
Drug: Oxandrolone with
RxNorm normalized name: Oxandrolone
DrugBank: Oxandrolone (DB00621)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxandrolone with enteral food supplement
Trial: 18056490
Drug: Femoral nerve
RxNorm normalized name: nerve growth factor
DrugBank: Nerve Growth Factor (DB12620)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Femoral nerve block (20 mL of 0.5% bupivacaine) along with standard pain management
Trial: 1353088
Drug: Topical antiseptics
RxNorm normalized name: Listerine Antiseptic
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical antiseptics (alcohol wipes and hexachlorophane powder)
Trial: 12571845
Drug: Triamcinolone acetonide
RxNorm normalized name: Triamcinolone Acetonide
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Triamcinolone acetonide 40 mg
Trial: 9349933
Drug: Oral 6-mercaptopurine
RxNorm normalized name: 6-Mercaptopurine
DrugBank: Mercaptopurine (DB01033)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral 6-mercaptopurine (50-165 mg.m-2.day-1)
Trial: 1534089
Drug: Goserelin 3.6
RxNorm normalized name: goserelin 3.6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Goserelin 3.6 mg monthly combined with oral MPA 15 mg daily for 6 months
Trial: 26122686
Drug: Robot-assisted therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Robot-assisted therapy + home exercise program
Trial: 20183391
Drug: Clinician-assisted emotional
RxNorm normalized name: DuoCare Clinical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clinician-assisted emotional disclosure therapy
Trial: 23906815
Drug: Noninvasive mechanical
RxNorm normalized name: PIPERONYL BUTOXIDE TECHNICAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Noninvasive mechanical ventilation (NIV) combined with conventional therapy
Trial: 29945674
Drug: Sirolimus treatment
RxNorm normalized name: Sirolimus
DrugBank: Sirolimus (DB00877)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Sirolimus treatment from month 4 to month 12 after an observational period.
Trial: 12946763
Drug: Levofloxacin 500
RxNorm normalized name: levofloxacin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levofloxacin 500 mg once daily for 28 days
Trial: 27565717
Drug: SMS reminder
RxNorm normalized name: Samarium Sm-153
DrugBank: Samarium Sm-153 (DB12905)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SMS reminder messages (monthly)
Trial: 11127759
Drug: Esterified estrogens
RxNorm normalized name: Esterified Estrogens
DrugBank: Esterified estrogens (DB09381)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esterified estrogens (0.3 mg, 0.625 mg, or 1.25 mg)
Trial: 7555975
Drug: Tiagabine (TGB)
DrugBank: Tiagabine (DB00906)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tiagabine (TGB) HCl, single doses of 2-24 mg
Trial: 7555975
Drug: Tiagabine (TGB)
DrugBank: Tiagabine (DB00906)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tiagabine (TGB) HCl, daily doses of 6 or 12 mg for 14 days
Trial: 23531117
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg norethisterone acetate (NETA)/1.0 mg E2
Trial: 28492195
Drug: Triclofos sodium
RxNorm normalized name: triclofos sodium
DrugBank: Triclofos (DB06753)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Triclofos sodium (70 mg/kg body weight)
Trial: 18820852
Drug: Low-protein diet
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-protein diet supplemented with keto-amino acids (100 mg/kg BW per day)
Trial: 29140444
Drug: Intramuscular control
RxNorm normalized name: Afeditab CR
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular control vaccine (hepatitis A)
Trial: 8946434
Drug: d-fenfluramine HCl
RxNorm normalized name: fenfluramine
DrugBank: Fenfluramine (DB00574)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d-fenfluramine HCl 0.5 mg/kg
Trial: 8946434
Drug: d-fenfluramine HCl
RxNorm normalized name: fenfluramine
DrugBank: Fenfluramine (DB00574)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d-fenfluramine HCl 1.0 mg/kg
Trial: 10400480
Drug: Azelastine nasal
RxNorm normalized name: azelastine nasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azelastine nasal spray (2 sprays per nostril bid, 1.1 mg/day)
Trial: 1878075
Drug: Alcoholic beverages
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alcoholic beverages (40 g alcohol) in the form of beer, red wine, or spirits
Trial: 15507864
Drug: Low-dose balsalazide
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose balsalazide (2.25 g/day) plus VSL#3 (3 g/day)
Trial: 12622761
Drug: Standard budesonide
RxNorm normalized name: Budesonide
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Standard budesonide capsules
Trial: 8017464
Drug: Fluvastatin 20
RxNorm normalized name: fluvastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin 20 mg/day
Trial: 10671903
Drug: MDMA 125
RxNorm normalized name: MDMA
DrugBank: Midomafetamine (DB01454)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MDMA 125 mg
Trial: 7707112
Drug: Treatment for
RxNorm normalized name: Hair Regrowth Treatment For Men
DrugBank: Minoxidil (DB00350)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Treatment for a 5-year increase in length of survival
Trial: 27207626
Drug: Feedback on
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Feedback on antihypertensive medications
Trial: 11784476
Drug: Ethanol 0
RxNorm normalized name: ethanol 0.1 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethanol 0 g/kg (placebo)
Trial: 8590608
Drug: Ethanol 0.35
RxNorm normalized name: ethanol 0.35 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethanol 0.35 g/kg
Trial: 31103123
Drug: Qigong practice
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Qigong practice (Guan Yin Zi Zai Gong level 1) for one hour per week for six weeks, encouraged to practice daily at home.
Trial: 23881309
Drug: internet-delivered cognitive
RxNorm normalized name: DELIVER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: internet-delivered cognitive behavior therapy (iCBT)
Trial: 27440192
Drug: 12 week
RxNorm normalized name: risedronate sodium 35 MG Oral Tablet, 12 Week Pack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12 week supervised exercise therapy
Trial: 7720759
Drug: HCTZ 12.5
RxNorm normalized name: HCTZ 12.5 MG Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HCTZ 12.5 mg b.i.d. (steady-state)
Trial: 3890601
Drug: Fenoterol inhalation
RxNorm normalized name: fenoterol
DrugBank: Fenoterol (DB01288)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenoterol inhalation powder
Trial: 30521533
Drug: Pregabalin treatment
RxNorm normalized name: Pregabalin
DrugBank: Pregabalin (DB00230)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Pregabalin treatment
Trial: 28915900
Drug: α-GalCer-pulsed dendritic
RxNorm normalized name: Dendritic cells vaccine
DrugBank: Dendritic cells vaccine (DB15803)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: α-GalCer-pulsed dendritic cell therapy
Trial: 7942668
Drug: Dual therapy
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual therapy with omeprazole 40 mg and amoxicillin
Trial: 24945932
Drug: Naloxegol 25
RxNorm normalized name: naloxegol 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naloxegol 25 mg single oral dose
Trial: 28531910
Drug: No intra-arterial
RxNorm normalized name: methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: No intra-arterial treatment (Control)
Trial: 8465408
Drug: Albendazole 600
RxNorm normalized name: Albendazole
DrugBank: Albendazole (DB00518)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Albendazole 600 mg
Trial: 11318574
Drug: Mebendazole 600
RxNorm normalized name: Mebendazole
DrugBank: Mebendazole (DB00643)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mebendazole 600 mg (2 doses per year)
Trial: 11318574
Drug: Mebendazole 600
RxNorm normalized name: Mebendazole
DrugBank: Mebendazole (DB00643)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mebendazole 600 mg (3 doses per year)
Trial: 3124593
Drug: High fat
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High fat intake (450 mg.kg‐1.d‐1) at 80 kcal.kg‐1.d‐1
Trial: 24914136
Drug: Alternative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alternative treatment (hydroxyurea/phlebotomy)
Trial: 30359438
Drug: 50 g
RxNorm normalized name: glucose 50 g/296 mL oral liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 g lactulose
Trial: 17532415
Drug: ET-A receptor
RxNorm normalized name: Toll-like receptor 9
DrugBank: Toll-like receptor 9 (DB15320)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ET-A receptor antagonist 2 mg/kg (n = 8)
Trial: 21228310
Drug: Metformin 1000
RxNorm normalized name: metformin 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin 1000 mg twice daily for 6 months
Trial: 26871201
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg pregabalin (PGL)
Trial: 24062546
Drug: Antenatal magnesium
RxNorm normalized name: Magnesium
DrugBank: Magnesium (DB14513)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antenatal magnesium sulfate (MgSO4) - initial dose 4 g, maintained at 1 g/h up to maximum of 24 h
Trial: 2203252
Drug: 5 g
RxNorm normalized name: 15 g/31 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 g FO, supplying 2 g n-3 fatty acids
Trial: 19196892
Drug: Digoxin therapy
RxNorm normalized name: Digoxin
DrugBank: Digoxin (DB00390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Digoxin therapy
Trial: 1627030
Drug: Serum cholesterol
RxNorm normalized name: Cholesterol
DrugBank: Cholesterol (DB04540)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serum cholesterol level less than 4.14 mmol/L (less than 160 mg/dL)
Trial: 26828770
Drug: Group-delivered integrated
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group-delivered integrated cognitive behavioral therapy
Trial: 24746411
Drug: Pulverized brand-name
RxNorm normalized name: Eagle Brand Medicated Oil
DrugBank: Eucalyptus oil (DB11114)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulverized brand-name and generic drugs containing amlodipine (Norvasc(®), Amlodipin‐Mepha(®), Amlodipin Pfizer(®))
Trial: 1702582
Drug: Adjunctive therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjunctive therapy
Trial: 12524069
Drug: Cyproterone acetate
RxNorm normalized name: cyproterone acetate
DrugBank: Cyproterone acetate (DB04839)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyproterone acetate (50 mg) with ethinyl estradiol (EE)
Trial: 6366807
Drug: Dithranol cream
RxNorm normalized name: Zithranol
DrugBank: Anthralin (DB11157)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dithranol cream 0.1%
Trial: 6366807
Drug: Dithranol ointment
RxNorm normalized name: Zithranol
DrugBank: Anthralin (DB11157)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dithranol ointment 0.25%
Trial: 7724298
Drug: Glucose-based oral
RxNorm normalized name: glucose Oral Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucose-based oral rehydration solution (Pedialyte)
Trial: 7724298
Drug: Rice syrup
RxNorm normalized name: Rice Syrup
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rice syrup solids-based ORS (Infalyte)
Trial: 18633172
Drug: Nifedipine 20
RxNorm normalized name: nifedipine 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine 20 mg
Trial: 9005368
Drug: Ipriflavone 600
RxNorm normalized name: IPRIFLAVONE
DrugBank: Ipriflavone (DB13618)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ipriflavone 600 mg/day per os
Trial: 9917047
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate nasal spray, 100 microg/day for 4 to 6 weeks
Trial: 27029706
Drug: Trebananib 15
RxNorm normalized name: Trebananib
DrugBank: Trebananib (DB12056)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trebananib 15 mg/kg QW plus weekly paclitaxel
Trial: 8760238
Drug: Amino acid
RxNorm normalized name: Amino Acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amino acid infusion (Vamin 9; Kabi Pharmacia) at 4 ml/min for 210 min
Trial: 22205149
Drug: Polymorphisms of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polymorphisms of estrogen receptor α
Trial: 16773438
Drug: Supportive-expressive group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supportive-expressive group therapy
Trial: 25467190
Drug: Gabapentin enacarbil
RxNorm normalized name: Gabapentin Enacarbil
DrugBank: Gabapentin enacarbil (DB08872)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gabapentin enacarbil (GEn) 600 mg + morphine 60 mg
Trial: 2401751
Drug: Norfloxacin 400
RxNorm normalized name: norfloxacin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Norfloxacin 400 mg bid
Trial: 31574047
Drug: Vaginal estrogen
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaginal estrogen cream
Trial: 17924869
Drug: Fenofibrate 80
RxNorm normalized name: Fenofibrate
DrugBank: Fenofibrate (DB01039)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fenofibrate 80 mg + Metformin 850 mg
Trial: 2956958
Drug: 1000 mg
RxNorm normalized name: bran 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 mg MPA daily for metastatic breast cancer (Group IV)
Trial: 8558934
Drug: Granulocyte colony-stimulating
RxNorm normalized name: Granulocyte colony-stimulating factor lenograstim
DrugBank: Lenograstim (DB13144)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granulocyte colony-stimulating factor (G-CSF) 10 micrograms/kg/day continuous i.v. infusion started 24 hours after chemotherapy completion.
Trial: 18027383
Drug: Methylprednisolone 10
RxNorm normalized name: methylprednisolone 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylprednisolone 10 mg/kg
Trial: 14762633
Drug: Chloroquine 600
RxNorm normalized name: Chloroquine
DrugBank: Chloroquine (DB00608)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chloroquine 600 mg on first day and 450 mg on second and third days (Group CHLO)
Trial: 14762633
Drug: Chloroquine single
RxNorm normalized name: Chloroquine
DrugBank: Chloroquine (DB00608)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chloroquine single dose treatment
Trial: 22613271
Drug: Intramuscular cholecalciferol
RxNorm normalized name: Cholecalciferol
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular cholecalciferol (600,000 IU)
Trial: 15346658
Drug: Tibolone 2.5
RxNorm normalized name: tibolone 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tibolone 2.5 mg/day
Trial: 22509426
Drug: Donor bone
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Donor bone marrow infusion (DBMI)
Trial: 12798615
Drug: TYPHIM Vi
RxNorm normalized name: Typhim VI
DrugBank: Typhoid Vi polysaccharide vaccine (DB10803)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TYPHIM Vi (control vaccine)
Trial: 12798615
Drug: tetanus toxoid
RxNorm normalized name: Tetanus Toxoid
DrugBank: Clostridium tetani toxoid antigen (formaldehyde inactivated) (DB10583)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: tetanus toxoid vaccine (control)
Trial: 8606270
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose dobutamine (20 to 40 microg/kg body weight per min)
Trial: 19935115
Drug: Bandage therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bandage therapy (BT)
Trial: 19935115
Drug: Bandage therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bandage therapy (BT) and Cast therapy (CT)
Trial: 28548024
Drug: Glimepiride up
RxNorm normalized name: Glimepiride
DrugBank: Glimepiride (DB00222)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glimepiride up to 6 mg once daily
Trial: 8901793
Drug: Calcium tablets
RxNorm normalized name: Leucovorin Calcium Tablets
DrugBank: Calcium sulfate (DB15533)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium tablets
Trial: 18369721
Drug: Three types
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three types of sex (vaginal, oral, and anal)
Trial: 15166554
Drug: Propofol and
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol and remifentanil combination
Trial: 2651367
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (17 infants with birthweight ≤ 1500 g and 20 infants with birthweight 1501-2000 g)
Trial: 31812149
Drug: Oral nimodipine
RxNorm normalized name: Nimodipine
DrugBank: Nimodipine (DB00393)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral nimodipine
Trial: 10525141
Drug: 20 mg/day
RxNorm normalized name: futibatinib 20 mg/day (4 mg x 5) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg/day of beta-carotene
Trial: 7723385
Drug: Low-dose monthly
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose monthly maintenance therapy
Trial: 11824878
Drug: 5-HT3 antagonists
RxNorm normalized name: Interleukin-1 receptor antagonist anakinra
DrugBank: Anakinra (DB00026)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: 5-HT3 antagonists (specific drugs not mentioned)
Trial: 9327336
Drug: Rectal immunization
RxNorm normalized name: Immune Globulin
DrugBank: Human immunoglobulin G (DB00028)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rectal immunization
Trial: 23016508
Drug: Vaginal progesterone
RxNorm normalized name: progesterone Vaginal Insert
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaginal progesterone (90 mg gel once daily)
Trial: 16113133
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg daily for 12 weeks
Trial: 12466367
Drug: Growth Hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth Hormone (GH) 6.25 micro g/kg sc daily
Trial: 12466367
Drug: Testosterone (T)
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone (T) transdermal patch 5.0 mg/daily